Adverse Pregnancy Outcomes and Future Metabolic Syndrome
- PMID: 37262199
- PMCID: PMC10510681
- DOI: 10.1089/jwh.2023.0026
Adverse Pregnancy Outcomes and Future Metabolic Syndrome
Abstract
Background: Metabolic syndrome (MetS) is associated with a history of gestational diabetes (GDM), hypertensive disorders of pregnancy (HDP), and preterm birth (PTB), but it is unclear whether this association is due to the pregnancy complication(s) or prepregnancy/early pregnancy confounders. The study examines the association of GDM, HDP, and PTB with MetS 2-7 years later, independent of early pregnancy factors. Materials and Methods: Large, diverse cohort of nulliparous pregnant people with singleton gestations enrolled during their first trimester and who attended a follow-up study visit 2-7 years after delivery. The longitudinal cohort was recruited from eight medical centers across the United States. Using standardized protocols, anthropometry, biospecimens, and surveys were collected at study visits and pregnancy outcomes were abstracted from medical records. We estimated the relative risk of prevalent MetS at the follow-up study visit for participants with GDM, HDP, or PTB (vs. no complications), adjusting for early pregnancy age, body mass index, self-reported race/ethnicity, insurance type, and smoking status. Results: Of 4,402 participants, 738 (16.8%) had MetS at follow-up: 13.1% (441/3,365) among those with no complications, and 27.9% (290/1,002) among those with complications. MetS occurred in 39.0% of GDM (73/187, adjusted relative risk [aRR] = 1.75; 95% confidence interval [CI] 1.42-2.16); 29.2% of HDP (176/603, aRR = 1.49; 95% CI 1.27-1.75); and 29.7% of PTB (113/380, aRR = 1.78; 95% CI 1.49-2.12). Those who had both HDP and PTB (n = 113) had an aRR = 1.95 (95% CI 1.50-2.54). Conclusions: People whose pregnancies were complicated by GDM, HDP, or PTB are at a higher risk of MetS within 2-7 years after delivery, independent of early pregnancy risk factors. The highest MetS risk follows pregnancies complicated by both HDP and PTB.
Keywords: cohort studies; metabolic syndrome; pregnancy complications.
Conflict of interest statement
Dr. Bairey Merz serves as a consultant/advisor for iRhythm. Dr. Saade is a consultant for GestVision. The authors report no other relevant financial or other conflicts of interest related to this project.
Figures
References
Publication types
MeSH terms
Grants and funding
- U10 HL119991/HL/NHLBI NIH HHS/United States
- T32 AI007358/AI/NIAID NIH HHS/United States
- U10 HL120018/HL/NHLBI NIH HHS/United States
- U10 HD063036/HD/NICHD NIH HHS/United States
- U10 HD063041/HD/NICHD NIH HHS/United States
- U10 HD063046/HD/NICHD NIH HHS/United States
- U10 HL119990/HL/NHLBI NIH HHS/United States
- U10 HD063020/HD/NICHD NIH HHS/United States
- U10 HD063053/HD/NICHD NIH HHS/United States
- UL1 TR001108/TR/NCATS NIH HHS/United States
- UL1 TR000153/TR/NCATS NIH HHS/United States
- U10 HD063072/HD/NICHD NIH HHS/United States
- U10 HL119992/HL/NHLBI NIH HHS/United States
- U10 HD063048/HD/NICHD NIH HHS/United States
- U10 HL120019/HL/NHLBI NIH HHS/United States
- U10 HD063047/HD/NICHD NIH HHS/United States
- U10 HL120006/HL/NHLBI NIH HHS/United States
- UL1 TR000439/TR/NCATS NIH HHS/United States
- UL1 TR000124/TR/NCATS NIH HHS/United States
- U10 HD063037/HD/NICHD NIH HHS/United States
- UL1 TR002548/TR/NCATS NIH HHS/United States
- U10 HL119989/HL/NHLBI NIH HHS/United States
- U10 HL119993/HL/NHLBI NIH HHS/United States
- UM1 TR004528/TR/NCATS NIH HHS/United States
- UL1 TR001881/TR/NCATS NIH HHS/United States
- U10 HL120034/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical